- Current report filing (8-K)
July 28 2010 - 4:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): 7/28/2010
LeMaitre Vascular, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 001-33092
|
|
|
Delaware
|
|
04-2825458
|
(State or other jurisdiction
of incorporation)
|
|
(IRS Employer
Identification No.)
|
63 Second Avenue
Burlington, MA 01803
(Address of principal executive offices, including zip code)
781-221-2266
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Information to be included in the report
Item 2.02.
|
Results of Operations and Financial Condition
|
On July 28, 2010, LeMaitre Vascular, Inc. issued a press release regarding its financial and operational results for the second
quarter ended June 30, 2010. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information in
this report, including the Exhibit attached hereto, is intended to be furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01.
|
Financial Statements and Exhibits
|
The following exhibit is furnished as part of this report, where indicated:
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Press release issued by LeMaitre Vascular, Inc. on July 28, 2010, announcing its financial and operational results for the second quarter ended June 30, 2010, furnished herewith.
|
Signature(s)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
LeMaitre Vascular, Inc.
|
|
|
|
|
Date: July 28, 2010
|
|
|
|
By:
|
|
/
S
/ A
ARON
M.
G
ROSSMAN
|
|
|
|
|
|
|
Aaron M. Grossman
|
|
|
|
|
|
|
Secretary
|
Exhibit Index
|
|
|
Exhibit
No.
|
|
Description
|
|
|
EX-99.1
|
|
Press Release
|
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From May 2024 to Jun 2024
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jun 2023 to Jun 2024